文献速递神经康复

可穿戴肌电接口MINT促进卒中后手臂活动恢复的随机对照试验

Wearable Myoelectric Interface for Neurorehabilitation (MINT) to Recover Arm Activity After Stroke: A Randomized Controlled Trial.
PubMed 文献 · Neurorehabil Neural Repair · 2026-06-08

该单盲随机假对照试验评估了家庭用肌电接口神经康复系统(MINT)对慢性卒中患者手臂活动的可行性和效果。3肌肉组在6周时WMFT改善6.8秒,联合MINT组改善4.1秒;10周时所有MINT组均显著改善而假组无改善。共激活减少与手臂功能改善显著相关,内囊病灶负向预测MINT反应。

要点

  • MINT训练可行,日均86分钟、315次重复,动机良好
  • 3肌肉组6周WMFT改善6.8秒,联合MINT组改善4.1秒
  • 共激活减少与手臂功能改善显著相关,内囊病灶负向预测反应

核心结论

  • MINT训练可行,能减少异常共激活并改善手臂运动和活动。

研究设计与样本

  • 单盲随机假对照试验,纳入中重度损伤的慢性卒中幸存者。
  • 参与者随机分为3个MINT组(分别训练2或3块异常共激活肌肉的定制游戏)或假对照组(训练1块肌肉)。
  • 训练方案为每天90分钟、每周6天,每2至3周切换上臂肌肉组。

主要发现

  • 3肌肉组在6周时WMFT改善6.8秒(95%CI 2.1-11.6秒,P=.001),其他组无显著改善。
  • 联合MINT组在6周时WMFT改善4.1秒(95%CI 1.4-6.8秒,P=.0008)。
  • 符合方案分析中,3肌肉组WMFT改善显著优于假组(7.5秒,95%CI 0.1-14.9秒,P=.046),肩/肘亚评分和运动学也改善。
  • 10周时所有MINT组均显著改善,假组无改善。
  • 共激活减少与手臂功能和运动改善显著相关;内囊病灶负向预测MINT反应。

关键数值与推荐

  • 主要疗效结局为各MINT组从基线至第6周WMFT变化与假组比较。
  • 3肌肉组6周WMFT改善6.8秒(95%CI 2.1-11.6秒,P=.001)。
  • 联合MINT组6周WMFT改善4.1秒(95%CI 1.4-6.8秒,P=.0008)。
  • 符合方案分析中3肌肉组WMFT改善7.5秒(95%CI 0.1-14.9秒,P=.046)优于假组。

临床怎么用

  • MINT可作为慢性卒中中重度手臂损伤患者的家庭可行训练方案。
  • 针对3块异常共激活肌肉的训练可能在6周内改善WMFT,10周时各组均获益。
  • 内囊病灶患者可能对MINT反应较差,需考虑个体化康复策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abnormal muscle co-activation impairs arm function after stroke. Home-based myoelectric interface for neurorehabilitation (MINT) was developed to reduce abnormal co-activation. OBJECTIVE: Evaluate MINT feasibility and effects on arm activity in a single-blind, randomized, sham-controlled trial. METHODS: Moderately-to-severely impaired chronic stroke survivors were randomized to 1 of 3 MINT groups (who played customized games requiring independent activation of 2 or 3 abnormally co-activating muscles) or a sham control group (using 1 muscle). Participants trained 90 minutes/day, 6 days/week, switching upper-arm muscle sets every 2 to 3 weeks. Feasibility was assessed using training time, repetitions, and motivation. The primary efficacy outcome was the change in Wolf Motor Function Test (WMFT) from baseline to week 6 in each MINT group compared to sham. Secondary outcomes included WMFT at week 10, WMFT subscores, Fugl-Meyer, Modified Ashworth, Motor Activity Log, reaching kinematics, co-activation, and lesion location effects. RESULTS: Fifty-nine participants completed training (mean: 86 ± 21 minutes/day, 315 ± 85 repetitions/day). The 3-muscle group improved WMFT by 6.8 seconds at week 6 (95% confidence interval [2.1-11.6 seconds], P = .001); other groups did not. Combined MINT groups improved by 4.1 seconds ([1.4-6.8 seconds], P = .0008). In per-protocol analysis, the 3-muscle group improved significantly more than sham on WMFT (7.5 seconds; [0.1-14.9 seconds], P = .046), shoulder/elbow subscores, and kinematics. At week 10, all MINT groups improved significantly, unlike sham. Reduced co-activation correlated significantly with improved arm function and movement. Stroke involving the internal capsule negatively predicted MINT response. Other secondary outcomes showed no clinically important changes. DISCUSSION: MINT conditioning is feasible, reduces co-activation, and improves arm movement and activity. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT03401762).

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Khorasani A, Gorski CM, Hung NT, et al. Wearable Myoelectric Interface for Neurorehabilitation (MINT) to Recover Arm Activity After Stroke: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2026. PMID: 42261097. doi:10.1177/15459683261454937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。